Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification

考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型

基本信息

  • 批准号:
    10685586
  • 负责人:
  • 金额:
    $ 17.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract This is a first submission for an NHLBI K23 Mentored Patient-Centered Career Development Award (PA-19- 119) by Christopher Knoepke, PhD, MSW, LCSW. Dr. Knoepke’s goal is to be a leading social work scientist improving the methods by which patients’ values are included as they consider advanced therapies. This proposal uses Transcatheter Aortic Valve Replacement (TAVR) as a model for studying decision support for cardiovascular disease patients generally. Candidate: Dr. Knoepke is a Licensed Clinical Social Worker who is currently an Assistant Research Professor in the Division of Cardiology at the University of Colorado School of Medicine. He has a Masters (Washington U. in St. Louis) and PhD in social work (U. of Denver). He works closely with his primary mentors (Drs. Daniel Matlock, MD, MPH & Larry Allen, MD, MHS), receiving mentorship from mentors/collaborators (including Drs. Russ Glasgow, Megan Morris, Eric Campbell, John Carroll, and Laura Scherer) through the Colorado Cardiovascular Outcomes Research Group (CCOR) & the University of Colorado’s Dissemination & Implementation Workgroup, and ACCORDS. Training/Mentors: This award augments Dr. Knoepke’s earlier training by focusing on three areas relevant to patient values in decision support:1) Advanced qualitative research; 2) clinician survey methodology; and 3) Dissemination & Implementation science. Dr. Knoepke proposes intensive mentorship; coursework & workshops, and contextual learning through the proposed research. Drs. Knoepke and Matlock have assembled a strong team of local mentors and collaborators to guide Dr. Knoepke through the training and research activities. These activities will enable Dr. Knoepke to innovatively develop decision support tools for real world care. Research: There is a pressing need to improve the science of clarifying implementing the assessment of patient values as they decide whether to accept advanced therapies. Advanced CVD patients are disproportionately offered such therapies. As advanced age & comorbidity can reduce expected benefits, the need to include patients’ values in decisions is paramount. This study will produce information relevant to clinical practice. Aim 1 will characterize the current state of practice in values clarification as it actually occurs between patients and care providers when they discuss TAVR. Aim 2 will include the development and deployment of a de novo survey of cardiology specialists, assessing design and contextual factors necessary to support dissemination of shared decision making in TAVR. Aim 3 will pragmatically pilot adapt a decision aid for older and/or high risk TAVR candidates (separately developed by Dr. Knoepke) to include findings from Aims 1 & 2. Summary: This award’s innovative collaboration between social work and cardiology will maximize implementation of findings and facilitate Dr. Knoepke’s development into a leader in improving how patient values are honored as they make complicated decisions about their health.
项目摘要/摘要 这是NHLBI K23导师以患者为中心的职业发展奖(PA-19- 119)作者克里斯托弗·诺普克,LCSW博士,MSW,LCSW。诺普克博士的目标是成为一名领先的社会工作科学家 改进在考虑先进疗法时纳入患者价值观的方法。这 建议使用经导管主动脉瓣置换术(TAVR)作为研究决策支持的模型 心血管疾病患者一般。候选人:诺普克博士是一名有执照的临床社会工作者 现任科罗拉多大学医学院心脏病学系助理研究教授 医学。他拥有硕士学位(华盛顿大学圣路易斯分校)和社会工作博士学位(丹佛大学)。他在工作 与他的主要导师(Daniel Matlock博士,医学博士,公共卫生硕士和Larry Allen,医学博士,MHS)密切合作,接受 来自导师/合作者的指导(包括Russ Glasgow博士、Megan Morris博士、Eric Campbell博士、John Carroll和Laura Scherer)通过科罗拉多州心血管结果研究小组(CCOR)和 科罗拉多大学传播与实施工作组,和ACCETS。培训/导师:这一点 该奖项加强了诺普克医生早期的培训,将重点放在决策中与患者价值相关的三个领域 支持:1)高级定性研究;2)临床医生调查方法;3)传播和 实施科学。诺普克博士建议加强导师指导、课程作业和研讨会,以及 通过拟议的研究进行情景学习。诺普克博士和马特洛克博士组建了一个强大的团队 由当地导师和合作者指导诺普克博士完成培训和研究活动。这些 这些活动将使诺普克博士能够创新地为现实世界的护理开发决策支持工具。研究: 迫切需要提高澄清实施患者价值评估的科学性 他们决定是否接受高级疗法。晚期心血管疾病患者被提供的比例不成比例 这样的疗法。由于高龄和共病可能会降低预期收益,因此有必要将患者的 决策中的价值至高无上。这项研究将产生与临床实践相关的信息。目标1将 描述当前在价值澄清方面的实践状态,因为它实际发生在患者和护理之间 提供商在讨论TAVR时。目标2将包括制定和部署一项从头调查 心脏病学专家,评估支持共享传播所需的设计和背景因素 TAVR中的决策。AIM 3将务实地试行调整决策辅助以适应较老和/或高风险的TAVR 候选人(由Knoepke博士分别开发),以包括AIMS 1和2的发现。总结: AWARD在社会工作和心脏病学之间的创新合作将最大限度地实施研究结果 并促进诺普克医生发展成为改善患者价值如何得到尊重的领导者 对他们的健康做出复杂的决定。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A comparative content analysis of newspaper coverage about extreme risk protection order policies in passing and non-passing US states.
  • DOI:
    10.1186/s12889-022-13374-8
  • 发表时间:
    2022-05-16
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Aubel, Amanda J.;Pallin, Rocco;Knoepke, Christopher E.;Wintemute, Garen J.;Kravitz-Wirtz, Nicole
  • 通讯作者:
    Kravitz-Wirtz, Nicole
The Advancing Understanding of Transportation Options (AUTO) study: design and methods of a multi-center study of decision aid for older drivers.
  • DOI:
    10.1186/s40621-021-00310-4
  • 发表时间:
    2021-05-03
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Betz ME;Omeragic F;Meador L;DiGuiseppi CG;Fowler NR;Han SD;Hill L;Johnson RL;Knoepke CE;Matlock DD;Moran R;AUTO Research Team
  • 通讯作者:
    AUTO Research Team
Experiences Implementing a Suite of Decision Aids for Implantable Cardioverter Defibrillators: Qualitative Insights From the DECIDE-ICD Trial.
  • DOI:
    10.1161/circoutcomes.122.009352
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Knoepke, Christopher E.;Wallace, Bryan C.;Allen, Larry A.;Lewis, Carmen L.;Gupta, Sanjaya K.;Peterson, Pamela N.;Kramer, Daniel B.;Brancato, Scott C.;Varosy, Paul D.;Mandrola, John M.;Tzou, Wendy S.;Matlock, Daniel D.
  • 通讯作者:
    Matlock, Daniel D.
Gun violence restraining orders in California, 2016-2018: case details and respondent mortality.
  • DOI:
    10.1136/injuryprev-2022-044544
  • 发表时间:
    2022-10
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Pear, Veronica A.;Pallin, Rocco;Schleimer, Julia P.;Tomsich, Elizabeth;Kravitz-Wirtz, Nicole;Shev, Aaron B.;Knoepke, Christopher E.;Wintemute, Garen J.
  • 通讯作者:
    Wintemute, Garen J.
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial.
一种电子传输的患者激活工具,用于强化治疗射血分数降低的慢性心力衰竭的药物:EPIC-HF 试验的基本原理和设计。
  • DOI:
    10.1016/j.ahj.2020.08.013
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Venechuk,GraceE;Khazanie,Prateeti;Page2nd,RobertL;Knoepke,ChristopherE;Helmkamp,LauraJ;Peterson,PamelaN;Pierce,Kenneth;Thompson,JocelynS;Huang,Janice;Strader,JamesR;Dow,TristanJ;Richards,Lance;Trinkley,KatyE;Kao,David
  • 通讯作者:
    Kao,David
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Knoepke其他文献

Christopher Knoepke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Knoepke', 18)}}的其他基金

Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10471806
  • 财政年份:
    2020
  • 资助金额:
    $ 17.02万
  • 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10222782
  • 财政年份:
    2020
  • 资助金额:
    $ 17.02万
  • 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10040875
  • 财政年份:
    2020
  • 资助金额:
    $ 17.02万
  • 项目类别:

相似海外基金

Closing Racial Disparities Through the Affordable Care Act: Medicaid Expansion, Marketplaces, Federally Qualified Community Health Centers
通过《平价医疗法案》缩小种族差异:医疗补助扩张、市场、联邦合格的社区卫生中心
  • 批准号:
    10717603
  • 财政年份:
    2023
  • 资助金额:
    $ 17.02万
  • 项目类别:
The Effects of the Affordable Care Act Medicaid Expansion on Informal Care
《平价医疗法案》医疗补助扩展对非正式医疗的影响
  • 批准号:
    10351420
  • 财政年份:
    2022
  • 资助金额:
    $ 17.02万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10201216
  • 财政年份:
    2021
  • 资助金额:
    $ 17.02万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10359441
  • 财政年份:
    2021
  • 资助金额:
    $ 17.02万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10533828
  • 财政年份:
    2021
  • 资助金额:
    $ 17.02万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10360535
  • 财政年份:
    2021
  • 资助金额:
    $ 17.02万
  • 项目类别:
The Impact of the Affordable Care Act (ACA) on Unintended Pregnancy: Combining epidemiological and econometric methods.
《平价医疗法案 (ACA)》对意外怀孕的影响:结合流行病学和计量经济学方法。
  • 批准号:
    10254272
  • 财政年份:
    2020
  • 资助金额:
    $ 17.02万
  • 项目类别:
Effects of Affordable Care Act Medicaid Expansion on Disparities in Trauma Care and Outcomes in Young Adults
平价医疗法案医疗补助扩大对年轻人创伤护理和结果差异的影响
  • 批准号:
    9922388
  • 财政年份:
    2019
  • 资助金额:
    $ 17.02万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10296663
  • 财政年份:
    2018
  • 资助金额:
    $ 17.02万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10063448
  • 财政年份:
    2018
  • 资助金额:
    $ 17.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了